• 2021-07-09

[Huayu-Molecular Biology Laboratory] In response to the COVID-19 epidemic alert extended to 7/26, the operation mode was adjusted.

• 2021-06-23

In response to the COVID-19 epidemic alert, the alert has been extended to 7/12, and the laboratory will be on 7/2 (Friday) and 7/9 (Friday) holidays

• 2021-06-09

In response to the COVID-19 epidemic alert extended to 6/28, the laboratory will be closed on 6/18 (Friday) and 6/25 (Friday).

• 2021-06-01

[Huayu-Molecular Biology Laboratory] should adjust its operation mode in response to the recent extension of the COVID-19 epidemic alert.

• 2021-05-27

Business Times-Aiming at RFA key technology patents Huayu signed a contract for the transfer of patent rights with Chang Gung University

• 2021-05-20

[Huayu-Molecular Biology Laboratory] should adjust its operation mode in response to the COVID-19 epidemic.

• 2020-09-07

The company and Genya Biotechnology Co., Ltd. jointly developed a new drug for the treatment of lupus erythematosus, GV17, and submitted a pre-IND meeting application to the U.S. FDA

• 2020-09-03

[Huayu-Molecular Biology Laboratory] Announcement of the new version of the inspection form (v5).

• 2019-12-27

[Huayu-Molecular Biology Laboratory] Announcement of Submission Form (v4).

• 2019-12-01

Development and treatment of pan-neuromyelitis